News

Select a year

2022

December 15, 2022. Tom Loeser appointed as CFO of T-CURX & T-CURX attending the 41st JPM Annual Healthcare Conference 2023

Read more

October 6, 2022. Ulf Grawunder, PhD, experienced Biotech Executive becomes new CEO of T-CURX

Read more

September 15, 2022. Caroline Burger, PhD, appointed as T-CURX' Global Head Business Development

Read more

July 12, 2022. Successful completion of non-clinical tissue cross reactivity study for the binder of T-CURX CAR-T cell pipeline product for AML patients

Read more